{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T04:05:20Z","timestamp":1746245120609,"version":"3.40.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,2]]},"DOI":"10.7759\/cureus.83337","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:50:19Z","timestamp":1746186619000},"source":"Crossref","is-referenced-by-count":0,"title":["Combination Therapy With Voclosporin and Anifrolumab in Two Patients With Lupus Nephritis and Discoid Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Arbor G","family":"Dykema","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziga","family":"Vodusek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralina","family":"Karagenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Homa","family":"Timlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12129","article-title":"Treat-to-target trials: uses, interpretation and review of concepts","volume":"16","author":"Garber AJ","year":"2014","unstructured":"Garber AJ. Treat-to-target trials: uses, interpretation and review of concepts. Diabetes Obes Metab. 2014, 16:193-205. 10.1111\/dom.12129","journal-title":"Diabetes Obes Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2023.59.2.3521876","article-title":"Anifrolumab in systemic lupus erythematosus","volume":"59","author":"Loncharich MF","year":"2023","unstructured":"Loncharich MF, Robertson I. Anifrolumab in systemic lupus erythematosus. Drugs Today (Barc). 2023, 59:53-61. 10.1358\/dot.2023.59.2.3521876","journal-title":"Drugs Today (Barc)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01488-z","article-title":"Voclosporin: first approval","volume":"81","author":"Heo YA","year":"2021","unstructured":"Heo YA. Voclosporin: first approval. Drugs. 2021, 81:605-10. 10.1007\/s40265-021-01488-z","journal-title":"Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06874-w","article-title":"Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial","volume":"23","author":"van Schaik M","year":"2022","unstructured":"van Schaik M, Arends EJ, Soonawala D, et al.. Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial. Trials. 2022, 23:939. 10.1186\/s13063-022-06874-w","journal-title":"Trials"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955","article-title":"Mortality in systemic lupus erythematosus","volume":"54","author":"Bernatsky S","year":"2006","unstructured":"Bernatsky S, Boivin JF, Joseph L, et al.. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006, 54:2550-7. 10.1002\/art.21955","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis","volume":"11","author":"Bastian HM","year":"2002","unstructured":"Bastian HM, Roseman JM, McGwin G Jr, et al.. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus. 2002, 11:152-60. 10.1191\/0961203302lu158oa","journal-title":"Lupus"},{"key":"ref7","article-title":"Corticosteroid Adverse Effects","author":"Yasir M","year":"2023","unstructured":"Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. StatPearls [Internet], Treasure Island (FL); 2023."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363865-combination-therapy-with-voclosporin-and-anifrolumab-in-two-patients-with-lupus-nephritis-and-discoid-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:50:20Z","timestamp":1746186620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363865-combination-therapy-with-voclosporin-and-anifrolumab-in-two-patients-with-lupus-nephritis-and-discoid-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.83337","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}